IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
Effect of calcitonin on anastrozole-induced bone pain during aromatase inhibitor therapy for breast cancer
Liu, P.; Yang, D. Q.; Xie, F.; Zhou, B.; Liu, M.
关键词Calcitonin Bone Pain Anastrozole Breast Cancer Aromatase Inhibitor
刊名GENETICS AND MOLECULAR RESEARCH
2014
DOI10.4238/2014.July.24.7
13期:3页:5285-5291
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Biochemistry & Molecular Biology ; Genetics & Heredity
研究领域[WOS]Biochemistry & Molecular Biology ; Genetics & Heredity
关键词[WOS]POSTOPERATIVE ADJUVANT CHEMOTHERAPY ; PROSTATE-CANCER ; OSTEOPOROSIS ; MANAGEMENT ; EFFICACY ; HORMONE
英文摘要

This study aimed to investigate calcitonin as an effective therapy for osteoporosis in patients with bone pain during the anastrozole treatment of breast cancer. Ninety-one patients, who were on anastrozole treatment for breast cancer and also suffered anastrozole-induced bone pain, were randomly divided into two groups: the calcitonin group received salmon calcitonin and Caltrate D, and the control group received Caltrate D. All patients were evaluated by the visual analogue scale (VAS) and underwent the dual energy x-ray absorptiometry test for bone mineral density (BMD), and serum osteocalcin (BGP), alkaline phosphatase (ALP), calcium (Ca), and phosphorus (P) were measured at three months before and after the treatment. Significant differences in serum Ca, P, BGP, and ALP were found in each group between before and after treatment (P < 0.05), while no differences between the calcitonin and control groups were found. No difference was observed in femur BMD between the two groups, or between before and after treatment in each group. There was a significant difference in spine BMD between before and after treatment in the control group (P < 0.05) but not in the calcitonin group, while no difference was found between the calcitonin and control groups. Futhermore, VAS score significantly declined in each group after treatment (P < 0.05), but much more in the calcitonin group than the control group (P < 0.05). Our finding suggests that calcitonin may alleviate bone pain during the anastrozole treatment of breast cancer but has no effect on bone loss during cancer treatment.

语种英语
WOS记录号WOS:000340383600061
Citation statistics
Cited Times:3[WOS]   [WOS Record]     [Related Records in WOS]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/51472
Collection北京大学第二临床医学院
北京大学第二临床医学院_乳腺外科
作者单位Peking Univ, Peoples Hosp, Dept Surg IV, Beijing 100871, Peoples R China
Recommended Citation
GB/T 7714
Liu, P.,Yang, D. Q.,Xie, F.,et al. Effect of calcitonin on anastrozole-induced bone pain during aromatase inhibitor therapy for breast cancer[J]. GENETICS AND MOLECULAR RESEARCH,2014,13(3):5285-5291.
APA Liu, P.,Yang, D. Q.,Xie, F.,Zhou, B.,&Liu, M..(2014).Effect of calcitonin on anastrozole-induced bone pain during aromatase inhibitor therapy for breast cancer.GENETICS AND MOLECULAR RESEARCH,13(3),5285-5291.
MLA Liu, P.,et al."Effect of calcitonin on anastrozole-induced bone pain during aromatase inhibitor therapy for breast cancer".GENETICS AND MOLECULAR RESEARCH 13.3(2014):5285-5291.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Liu, P.]'s Articles
[Yang, D. Q.]'s Articles
[Xie, F.]'s Articles
百度学术
百度学术Similar articles in
[Liu, P.]'s Articles
[Yang, D. Q.]'s Articles
[Xie, F.]'s Articles
必应学术
必应学术Similar articles in
[Liu, P.]'s Articles
[Yang, D. Q.]'s Articles
[Xie, F.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.